Literature DB >> 3920001

Biochemical and biological properties of interleukin-3: a lymphokine mediating the differentiation of a lineage of cells that includes prothymocytes and mastlike cells.

J N Ihle.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3920001     DOI: 10.1007/978-1-4684-4838-2_4

Source DB:  PubMed          Journal:  Contemp Top Mol Immunol        ISSN: 0090-8800


× No keyword cloud information.
  7 in total

1.  Repression of Id2 expression by Gfi-1 is required for B-cell and myeloid development.

Authors:  Huajie Li; Ming Ji; Kimberly D Klarmann; Jonathan R Keller
Journal:  Blood       Date:  2010-05-07       Impact factor: 22.113

2.  Functional characterization of Con A-responsive Lyt2-positive mouse small intestinal intraepithelial lymphocytes.

Authors:  S B Dillon; T T MacDonald
Journal:  Immunology       Date:  1986-11       Impact factor: 7.397

3.  EVI1 Interferes with Myeloid Maturation via Transcriptional Repression of Cebpa, via Binding to Two Far Downstream Regulatory Elements.

Authors:  Michael Wilson; Vasiliki Tsakraklides; Minh Tran; Ying-Yi Xiao; Yi Zhang; Archibald S Perkins
Journal:  J Biol Chem       Date:  2016-04-21       Impact factor: 5.157

4.  Modulation of c-kit mRNA and protein by hemopoietic growth factors.

Authors:  M J Welham; J W Schrader
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

5.  p53 facilitates pRb cleavage in IL-3-deprived cells: novel pro-apoptotic activity of p53.

Authors:  E Gottlieb; M Oren
Journal:  EMBO J       Date:  1998-07-01       Impact factor: 11.598

6.  GILZ inhibits the mTORC2/AKT pathway in BCR-ABL(+) cells.

Authors:  S Joha; A-L Nugues; D Hétuin; C Berthon; X Dezitter; V Dauphin; F-X Mahon; C Roche-Lestienne; C Preudhomme; B Quesnel; T Idziorek
Journal:  Oncogene       Date:  2011-08-01       Impact factor: 9.867

7.  Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal.

Authors:  E Gottlieb; R Haffner; T von Rüden; E F Wagner; M Oren
Journal:  EMBO J       Date:  1994-03-15       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.